Cook Pharmica has signed an agreement with Inspiration Biopharmaceuticals to conduct development work for its lead biologic therapy, an intravenous Factor IX product for patients with hemophilia B. Activities will be performed in Cook Pharmica’s development laboratory within its Bloomington, Ind. facility. Cook Pharmica is the contract biopharmaceutical manufacturing and development services division of Cook Medical. “We are very excited to join with Inspiration Biopharmaceuticals...